Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial

Citation
Verma S, Mazer CD, Yan AT, et al. Circulation 2019;140:1693–702.